EBS Technologies | Updates

By Team EBS Technologies

EBS Creates Website Specifically for Patients


Dear Companists,

Since the launch of our equity crowdfunding campaign, many things have happened because the investments we received from many Companists enabled us to implement some first projects (for instance the patient registry we have already told you about).

These projects include a website made specifically for patients – a landing page – among other things. Perhaps many of you are now wondering why we had another website created in addition to our normal company website.

Today, an increasing number of patients want to be able to make their own decisions about therapy methods. Such decisions are no longer based solely on communication between patients and doctors. However, many patients lack the knowledge necessary to properly assess more complex medical texts. Consequently, it is particularly important that information be provided in a comprehensible, yet reliable high-quality fashion. This information also has to be made available where patients can find it, which can be done most effectively on the Internet today.


Patients may access our landing page at www.ebs-therapie.de

Through this landing page, we want to directly address patients with visible impairments due to neurological reasons and these patients' families. The page has been designed in a way that enables users to easily access information on visual field loss and the related therapy options. Moreover, the page's design enables users to directly contact us or therapy centers.



Thus, we will raise awareness of the EBS therapy method and increase the number of patients willing to undergo this treatment.

We will also start focusing on our other projects very soon. The most important of these projects is the creation of our patient registry, which will enable us to have therapy results analyzed statistically by independent experts.

As these projects are essential to the further development of EBS Technologies, we would like to thank you very much for your excellent support!

Best regards,

The EBS Technologies Team


Only registered Companists can comment. Please log in to leave a comment.


Investments in startups and growth companies offer great opportunities, but they are risk investments. In the worst case, the entire investment amount may be lost. Consequently, investments in startups or growth companies are unsuitable for retirement plans. However, there is no obligation to make further contributions. Investors can minimize their risk by diversifying the amount they invest in startups and growth companies and not investing the entire amount in one startup or growth company. Professional investors often follow this strategy because it causes the risk to be distributed among several investments. In this way, successful investments can balance other less successful investments.

The shares of the investors on Companisto are subordinated profit-participating loans (partiarische Nachrangdarlehen). Such loans are shares in a business with similar characteristics as equity. If the company becomes insolvent or is liquidated, the claims of the investors (Companists) – just like those of all other shareholders of the company – will be satisfied from the assets in the insolvency or the assets in liquidation only after the claims of all other external creditors have been satisfied. Thus, Companists are treated like any other shareholder of the company during insolvency or liquidation proceedings.

The company information published on the Companisto website is provided solely by the companies. The projections made by the companies do not guarantee successful development of the company in the future. Consequently, investments in startups and growth companies are suitable only for those investors who can cope with the risk of a total loss of the capital invested. Investors make their own independent investment decisions and bear all risks themselves.

The investments are provided and issued by the individual companies. Companisto is neither the provider nor the issuer of the investments, but solely the internet service platform.

€ 258,825


3.67 %

Share Offered

Please note
The acquisition of the offered securities and investments is associated with considerable risks and can lead to the complete loss of the invested assets. The expected yield is not guaranteed and may be lower. Whether it is a security or an asset investment can be seen in the description of the investment opportunity.
Contact Us
If you have any questions about investing on Companisto, please contact our service team:

Toll-free phone number for investors calling from Germany:
0800 - 100 267 0

Companisto investors hotline:
+49(0)30 - 346 491 493

We are available Monday through Friday between 9 a.m. – 6 p.m.

For companies
Apply for financing Investment Model FAQ for Companies
Investor Support
Please register in order to see the complete profile of EBS Technologies.
Already registered?    Log in